A detailed history of Pine Bridge Investments, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 1,216,440 shares of BMY stock, worth $71.6 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,216,440
Previous 1,381,308 11.94%
Holding current value
$71.6 Million
Previous $57.4 Million 9.74%
% of portfolio
0.48%
Previous 0.47%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $6.54 Million - $8.53 Million
-164,868 Reduced 11.94%
1,216,440 $63 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $9.42 Million - $12.4 Million
-233,999 Reduced 14.49%
1,381,308 $57.4 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $11.2 Million - $12.7 Million
-232,622 Reduced 12.59%
1,615,307 $87.6 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $37.5 Million - $44.7 Million
772,635 Added 71.85%
1,847,929 $94.8 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $19.1 Million - $21.4 Million
329,978 Added 44.27%
1,075,294 $62.4 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $7.32 Million - $8.12 Million
114,830 Added 18.21%
745,316 $47.7 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $1.84 Million - $2.09 Million
-28,055 Reduced 4.26%
630,486 $43.7 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $5.41 Million - $6.41 Million
79,034 Added 13.64%
658,541 $47.4 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $12,364 - $7.31 Million
95,111 Added 19.63%
579,507 $41.2 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $19.1 Million - $21 Million
262,382 Added 118.18%
484,396 $37.3 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $11.5 Million - $13.7 Million
-186,329 Reduced 45.63%
222,014 $16.2 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $823,059 - $959,494
15,347 Added 3.91%
408,343 $25.5 Million
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $2.62 Million - $3.07 Million
44,274 Added 12.7%
392,996 $23.3 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $847,300 - $922,710
-13,686 Reduced 3.78%
348,722 $23.3 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $296,284 - $333,232
4,993 Added 1.4%
362,408 $22.9 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $3.52 Million - $3.98 Million
-60,884 Reduced 14.56%
357,415 $22.2 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $1.63 Million - $1.81 Million
28,374 Added 7.28%
418,299 $25.2 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $2.24 Million - $2.62 Million
-40,917 Reduced 9.5%
389,925 $22.9 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $898,443 - $1.31 Million
-19,363 Reduced 4.3%
430,842 $24 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $246,443 - $321,463
5,008 Added 1.12%
450,205 $28.9 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $8.38 Million - $9.94 Million
-195,924 Reduced 30.56%
445,197 $22.6 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $2.99 Million - $3.31 Million
67,027 Added 11.68%
641,121 $29.1 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $6.37 Million - $7.6 Million
141,205 Added 32.62%
574,094 $27.4 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $1.26 Million - $1.63 Million
-25,776 Reduced 5.62%
432,889 $22.5 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $8.61 Million - $9.71 Million
156,041 Added 51.56%
458,665 $28.5 Million
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $15.2 Million - $18.9 Million
299,997 Added 11419.76%
302,624 $16.7 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $41,045 - $47,251
685 Added 35.27%
2,627 $167,000
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $24,935 - $27,185
416 Added 27.26%
1,942 $119,000
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $154,146 - $177,898
-2,791 Reduced 64.65%
1,526 $97,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,317
4,317 $240,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.